For decades, the childhood and adolescent immunization schedule has called for administering vaccines at set milestones.

Biological E.’s 14-valent pneumococcal vaccine receives WHO pre-qualification, enhancing global access to essential immunization for children.

Biological E's Pneubevax 14 vaccine gains WHO pre-qualification, enhancing global access to vital pneumococcal disease protection for children.

Every parent wants their child to grow up healthy, curious, and safe — and to those who might be taking a step forward to ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story HHS’s latest vaccine policy upheaval A ...

Hyderabad: Biological E's 14-valent pneumococcal conjugate vaccine, PNEUBEVAX-14, has received pre-qualification (PQ) from ...

Experts who spoke with MedPage Today also pointed to the impact of pneumococcal vaccines. Though a vaccine for adults was available decades earlier, the turn of the century brought one for kids that ...

Hyderabad: Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company, has announced that the World Health ...

ACIP has drifted toward inflating speculative risks while downplaying well-established vaccine benefits,” write former CDC ...

Sen. Bill Cassidy (R-La.) on Sunday said he is “very concerned” about the possibility of changing the hepatitis B vaccine schedule for infants in the United States. Health and Human Services Secretary ...

The Gates Foundation rings the alarm on the century's first reversal in progress to save the worlds poorest children, ...

Rising Cases of Invasive Pneumococcal Disease in Adults Over 50 Spark Warning Thunder Bay – Health News – The Thunder Bay ...